U.S. giant takes aim at Vancouver’s Precision NanoSystems with latest acquisition deal Jun 9, 2021 | In the News
Nurix Therapeutics Announces Presentation of Preclinical Data from NX-5948 Program Demonstrating Significant Reduction of Inflammation in a Model of Autoimmune Disease Jun 9, 2021 | In the News
We are thrilled to announce that Cardlytics will acquire, Bridg in a US$350m deal, plus earnout. Jun 9, 2021 | In the News